Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, and medtech. Founded in 1999, with a history of well-known successes, we closed our current capital pool of $1.5 billion in 2012 and are actively funding healthcare innovation.
We start companies, or invest in existing companies, with commitments as high as $250 million; in this sense, we scale to the buy-out or growth equity level. But we take the long view, both as a matter of principle and for value creation. An ATP company may choose to sell in an M&A transaction, but only if the price is right, or may access the public markets, but only if advantageous to do so.
This means our managers can build with confidence, knowing that we are funding them to grow and develop their businesses.
We are headquartered in New York City.
About Apple Tree Partners
Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, and medtech. Founded in 1999, with a history of well-known successes, we closed our current capital pool of $1.5 billion in 2012 and are actively funding healthcare innovation.
We start companies, or invest in existing companies, with commitments as high as $250 million; in this sense, we scale to the buy-out or growth equity level. But we take the long view, both as a matter of principle and for value creation. An ATP company may choose to sell in an M&A transaction, but only if the price is right, or may access the public markets, but only if advantageous to do so.
This means our managers can build with confidence, knowing that we are funding them to grow and develop their businesses.
We are headquartered in New York City.
We use cookies to offer you a better experience, analyze site traffic, and serve targeted advertisements. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.